Literature DB >> 19177158

Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway.

Sanjeev Sethi1, Jeffrey D Gamez, Julie A Vrana, Jason D Theis, H Robert Bergen, Peter F Zipfel, Ahmet Dogan, Richard J H Smith.   

Abstract

Dense Deposit Disease (DDD), or membranoproliferative glomerulonephritis type II, is a rare renal disease characterized by dense deposits in the mesangium and along the glomerular basement membranes that can be seen by electron microscopy. Although these deposits contain complement factor C3, as determined by immunofluorescence microscopy, their precise composition remains unknown. To address this question, we used mass spectrometry to identify the proteins in laser microdissected glomeruli isolated from paraffin-embedded tissue of eight confirmed cases of DDD. Compared to glomeruli from five control patients, we found that all of the glomeruli from patients with DDD contain components of the alternative pathway and terminal complement complex. Factor C9 was uniformly present as well as the two fluid-phase regulators of terminal complement complex clusterin and vitronectin. In contrast, in nine patients with immune complex-mediated membranoproliferative glomerulonephritis, glomerular samples contained mainly immunoglobulins and complement factors C3 and C4. Our study shows that in addition to fluid-phase dysregulation of the alternative pathway, soluble components of the terminal complement complex contribute to glomerular lesions found in DDD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19177158      PMCID: PMC2738640          DOI: 10.1038/ki.2008.657

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  39 in total

1.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

2.  A statistical model for identifying proteins by tandem mass spectrometry.

Authors:  Alexey I Nesvizhskii; Andrew Keller; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2003-09-01       Impact factor: 6.986

3.  Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man.

Authors:  G Utermann; M Hees; A Steinmetz
Journal:  Nature       Date:  1977-10-13       Impact factor: 49.962

4.  Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo.

Authors:  Aldo Dobrina; Mario Pausa; Fabio Fischetti; Roberta Bulla; Elena Vecile; Elisabetta Ferrero; Alberto Mantovani; Francesco Tedesco
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

5.  Complement analysis in children with idiopathic membranoproliferative glomerulonephritis: a long-term follow-up.

Authors:  R Schwertz; U Rother; D Anders; N Gretz; K Schärer; M Kirschfink
Journal:  Pediatr Allergy Immunol       Date:  2001-06       Impact factor: 6.377

6.  A protective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion.

Authors:  G Chen; L Paka; Y Kako; P Singhal; W Duan; S Pillarisetti
Journal:  J Biol Chem       Date:  2001-09-28       Impact factor: 5.157

7.  Composition of nephritic factor-generated glomerular deposits in membranoproliferative glomerulonephritis type 2.

Authors:  C D West; D P Witte; A J McAdams
Journal:  Am J Kidney Dis       Date:  2001-06       Impact factor: 8.860

8.  The membrane attack complex of complement induces caspase activation and apoptosis.

Authors:  Alma J Nauta; Mohamed R Daha; Odette Tijsma; Bob van de Water; Francesco Tedesco; Anja Roos
Journal:  Eur J Immunol       Date:  2002-03       Impact factor: 5.532

Review 9.  Factor H family proteins: on complement, microbes and human diseases.

Authors:  P F Zipfel; C Skerka; J Hellwage; S T Jokiranta; S Meri; V Brade; P Kraiczy; M Noris; G Remuzzi
Journal:  Biochem Soc Trans       Date:  2002-11       Impact factor: 5.407

10.  Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H.

Authors:  Matthew C Pickering; H Terence Cook; Joanna Warren; Anne E Bygrave; Jill Moss; Mark J Walport; Marina Botto
Journal:  Nat Genet       Date:  2002-07-01       Impact factor: 38.330

View more
  72 in total

Review 1.  C3 glomerulopathy: a new classification.

Authors:  Fadi Fakhouri; Véronique Frémeaux-Bacchi; Laure-Hélène Noël; H Terence Cook; Matthew C Pickering
Journal:  Nat Rev Nephrol       Date:  2010-07-06       Impact factor: 28.314

2.  Overlap of ultrastructural findings in C3 glomerulonephritis and dense deposit disease.

Authors:  Sanjeev Sethi; Fernando C Fervenza; Richard J H Smith; Mark Haas
Journal:  Kidney Int       Date:  2015-12       Impact factor: 10.612

3.  Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis.

Authors:  Sanjeev Sethi; Jason D Theis; Nelson Leung; Angela Dispenzieri; Samih H Nasr; Mary E Fidler; Lynn D Cornell; Jeffrey D Gamez; Julie A Vrana; Ahmet Dogan
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-28       Impact factor: 8.237

4.  American Society of Nephrology clinical pathological conference.

Authors:  Kevin E Meyers; Helen Liapis; Mohamed G Atta
Journal:  Clin J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 8.237

Review 5.  Review: Complement and its regulatory proteins in kidney diseases.

Authors:  Allison M Lesher; Wen-Chao Song
Journal:  Nephrology (Carlton)       Date:  2010-10       Impact factor: 2.506

Review 6.  Complement regulators and inhibitory proteins.

Authors:  Peter F Zipfel; Christine Skerka
Journal:  Nat Rev Immunol       Date:  2009-09-04       Impact factor: 53.106

Review 7.  C3 Glomerulopathy.

Authors:  Magdalena Riedl; Paul Thorner; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2016-04-07       Impact factor: 3.714

8.  Allelic variants of complement genes associated with dense deposit disease.

Authors:  Maria Asuncion Abrera-Abeleda; Carla Nishimura; Kathy Frees; Michael Jones; Tara Maga; Louis M Katz; Yuzhou Zhang; Richard J H Smith
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

Review 9.  Changing the concepts of immune-mediated glomerular diseases through proteomics.

Authors:  Dawn J Caster; Liliane Hobeika; Jon B Klein; David W Powell; Kenneth R McLeish
Journal:  Proteomics Clin Appl       Date:  2015-06-17       Impact factor: 3.494

10.  Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase.

Authors:  Danielle Paixão-Cavalcante; Steven Hanson; Marina Botto; H Terence Cook; Matthew C Pickering
Journal:  Mol Immunol       Date:  2009-05-02       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.